Contraceptive choices for chronically ill adolescents

Adolescent Medicine Clinics

Volumn 16, Issue 3 SPEC. ISS., 2005, Pages 635-644

  Gittes, Elissa B ^a,b,c   Strickland, Julie L ^a,b  

^a UNIVERSITY OF MISSOURI KANSAS CITY SCHOOL OF MEDICINE   (United States)

^b CHILDREN S MERCY HOSPITAL   (United States)

^c Department of Pediatrics   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 25844469108     PISSN: 15473368     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.admecli.2005.05.002     Document Type: Review

References (33)

1. K. Heroux Contraceptive choices in medically ill adolescents Semin Reprod Med 21 4 2003 389 398
2. J.C. Suris, M.D. Resnick, N. Cassuto, and R.W. Blum Sexual behavior of adolescents with chronic disease and disability J Adolesc Health 19 2 1996 124 131
3. R.H. Mattson, and R.W. Rebar Contraceptive methods for women with neurologic disorders Am J Obstet Gynecol 168 1993 2027 2032
4. Collaborative Group for the Study of Stroke in Young Women Associated risk factors JAMA 231 1975 718 722
5. K. Heroux Contraceptive choices in medically ill adolescents Semin Reprod Med 21 4 2003 389 398
6. L. Neinstein, and B. Katz Contraceptive use in the chronically ill adolescent female. Part II J Adolesc Health Care 7 5 1986 350 360
7. P. Crawford Interactions between antiepileptic drugs and hormonal contraception CNS Drugs 16 2002 263 272
8. D.J. Back, and M.L. Orne Pharmacokinetic drug interactions with oral contraceptives Clin Pharmacokinet 18 1990 472 484
9. P. Crawford, D.J. Chadwick, and C. Martin The interaction of ohenytoin and carbamazepine with combined oral contraceptive steroids Br J Clin Pharmacol 30 1990 892 896
10. V. Saano Effects of felbamate on the pharmacokinetics of a low-dose combination oral contraceptive Clin Pharmacol Ther 58 1995 523 531
11. W.E. Rosenfeld Effect of topiramate on the pharmacokinetics of an oral contraceptive containing norethindrone and ethinyl estradiol in patients with epilepsy Epilepsia 38 1997 317 323
12. P. Crawford The lack of effect of sodium valproate on the pharmacokinetics of oral contraceptive steroids Contraception 33 1986 23 29
13. M.A. Eldon Gabapentin does not interact with a contraceptive regimen of norethindrone acetate and ethinyl estradiol Neurology 50 1998 1146 1148
14. H.B. Mengel, A. Houston, and D.J. Back An evaluation of the interaction between tiagabine and oral contraceptives in female volunteers Journal of Pharmaceutical Medicine 4 1994 141 150
15. S. Natsch, Y.A. Hekster, and A. Keyser Newer anticonvulsant drugs: role of Pharmacology, drug interactions and adverse reactions in drug choice Drug Saf 17 1997 228 240
16. L.B. Holmes, E.A. Harvey, and B.A. Coull The teratogenicity of anticonvulsant drugs N Engl J Med 344 2001 1132 1138
17. E.K. Sapire Depo Provera and carbamazepine [letter] Br J Fam Plann 15 1990 130
18. R. Mattson, and R. Rebar Contraceptive method for women with neurological disorders Am J Obstet Gynecol 168 1993 2027 2032
19. A.M. Kaunitz, and J. Mestman Hormonal contraception in women with common medical conditions: Benefits and risk of use Dialogues Contracept 8 6 2004 1 7
20. American College of Obstetricians and Gynecologists The use of hormonal contraception in women with coexisting medical conditions ACOG Practice Bulletin 18 2000 1 13
21. W.N. Spellacy, J.C. Tsibris, and D.L. Hunter-Bonner Six-month carbohydrate metabolism studies in women using oral contraceptives containing gestodene and ethinyl estradiol Contraception 45 6 1992 533 539
22. M. Frederiksen Depot medroxy progesterone acetate concentration in women with medical problems J Reprod Med 41 1996 414 418
23. K. Heroux Contraceptive choices in medically ill adolescents Semin Reprod Med 21 4 2003 389 398
24. F. Cardoso, J. Polonia, and A. Santos Low-dose oral contraceptives and 24-hour ambulatory blood pressure Int J Gynaecol Obstet 59 1997 237 243
25. WHO Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception Ischemic stroke and combined oral contraceptives: results of an international, multi-centre, case-control study Lancet 348 1996 498 505
26. S. Sidney, D.S. Siscovick, and D.B. Petitti Myocardial infarction and use of low-dose oral contraceptives: a pooled analysis of 2 US studies Circulation 98 1998 1058 1063
27. S.M. Schwartz, D.B. Petitti, and D.S. Siscovick Stroke and the use of low-dose oral contraceptives in young women: a pooled analysis of two US studies Stroke 29 1998 2277 2284
28. J.K. Andersson, and G. Rybo Levonorgestrel-releasing intrauterine device in the treatment of menorrhagia Br J Obstet Gynaecol 97 1990 690 694
29. B.A. Cromer, J.M. Blair, and J.D. Mahan A prospective comparison of bone density in adolescent girls receiving depot medroxyprogesterone acetate (Depo Provera), levonorgestrel (Norplant), and oral contraceptives J Pediatr 129 1996 671 676
30. S.K. Khoo, and J.F. Correy Contraception and the high risk woman Med J Aust 1 1981 60 68
31. G.E. Robinson, T. Burren, and I.J. Mackie Changes in haemostasis after stopping the combined contraceptive pill: Implications for major surgery BMJ 302 1991 269 271
32. M. Frederiksen Depot medroxy progesterone acetate concentration in women with medical problems J Reprod Med 41 1996 414 418
33. M. Petri, and C. Robinson Oral contraceptives and systemic lupus erythematosis Arthritis Rheum 40 1997 797 803